CALLIE HAPUARACHY: Open Payments
NPI 1730706441 · CHARLESTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$181 in 9 payments from 4 companies in 2025. Trend: 2023 $215 · 2024 $322 · 2025 $181
Food & beverage: $181
| Company | Payments | Amount |
|---|---|---|
| Celgene Corporation | 3 | $70 |
| E.R. Squibb & Sons, L.L.C. | 3 | $49 |
| Novartis Pharmaceuticals Corporation | 2 | $41 |
| BeOne Medicines USA, Inc. | 1 | $20 |
Products named: REBLOZYL, OPDUALAG, SCEMBLIX, TEVIMBRA, KISQALI, OPDIVO.
Industry payments across WV — which companies pay providers there.
